MAGED1 and neoplasm: To further investigate whether the presence of tumor cells expressing only one natural CTA is sufficient to alter overall ICI responsiveness, either a type 1 or type 2 frameshift mutation was introduced by knocking in 2 or 1 nucleotides, respectively, at the murine melanoma-associated antigen D1 (Magd1) gene locus (Fig. 7 A).